Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2017 Jun 27;61(7):e00115-17. doi: 10.1128/AAC.00115-17

Terbinafine Resistance of Trichophyton Clinical Isolates Caused by Specific Point Mutations in the Squalene Epoxidase Gene

Tsuyoshi Yamada a,b, Mari Maeda a, Mohamed Mahdi Alshahni b, Reiko Tanaka c, Takashi Yaguchi c, Olympia Bontems d, Karine Salamin d, Marina Fratti d, Michel Monod d,
PMCID: PMC5487658  PMID: 28416557

ABSTRACT

Terbinafine is one of the allylamine antifungal agents whose target is squalene epoxidase (SQLE). This agent has been extensively used in the therapy of dermatophyte infections. The incidence of patients with tinea pedis or unguium tolerant to terbinafine treatment prompted us to screen the terbinafine resistance of all Trichophyton clinical isolates from the laboratory of the Centre Hospitalier Universitaire Vaudois collected over a 3-year period and to identify their mechanism of resistance. Among 2,056 tested isolates, 17 (≈1%) showed reduced terbinafine susceptibility, and all of these were found to harbor SQLE gene alleles with different single point mutations, leading to single amino acid substitutions at one of four positions (Leu393, Phe397, Phe415, and His440) of the SQLE protein. Point mutations leading to the corresponding amino acid substitutions were introduced into the endogenous SQLE gene of a terbinafine-sensitive Arthroderma vanbreuseghemii (formerly Trichophyton mentagrophytes) strain. All of the generated A. vanbreuseghemii transformants expressing mutated SQLE proteins exhibited obvious terbinafine-resistant phenotypes compared to the phenotypes of the parent strain and of transformants expressing wild-type SQLE proteins. Nearly identical phenotypes were also observed in A. vanbreuseghemii transformants expressing mutant forms of Trichophyton rubrum SQLE proteins. Considering that the genome size of dermatophytes is about 22 Mb, the frequency of terbinafine-resistant clinical isolates was strikingly high. Increased exposure to antifungal drugs could favor the generation of resistant strains.

KEYWORDS: dermatophytes, squalene epoxidase, terbinafine, Trichophyton, antifungal resistance, reverse genetics approach

INTRODUCTION

Tinea pedis and tinea unguium are the most prevalent dermatophytoses. Both are generally caused by Trichophyton rubrum and Trichophyton interdigitale, with prevalences of approximately 80% and 20%, respectively (1). Control of tinea pedis and tinea unguium requires treatment with topical and/or oral fungicidal or fungistatic drugs (2). With some exceptions, antifungal drugs commonly used to treat dermatophytosis target the ergosterol biosynthetic pathway. Imidazoles such as econazole and triazoles such as itraconazole inhibit lanosterol 14-α-demethylase, which leads to the accumulation of sterol precursors and results in altered plasma membrane structure and function (3). In contrast, allylamines such as terbinafine are inhibitors of squalene epoxidase, an enzyme involved in the early steps of ergosterol biosynthesis (4). This inhibition results in the accumulation of squalene, which is toxic to fungi (5). Terbinafine has been found to be (as the drug of choice) efficacious for curing both tinea pedis and tinea unguium and is now used worldwide.

Although T. rubrum clinical isolates resistant to terbinafine are rarely described in the literature, therapeutic failure has been recorded in Lausanne (Switzerland) in patients with tinea pedis or onychomycosis. In these cases, the infectious agent was unambiguously identified as T. rubrum. To date, only two cases of terbinafine resistance have been investigated at the biochemical and DNA levels in T. rubrum clinical isolates from onychomycoses (69). Resistance was shown to be due to single point mutations in the gene encoding squalene epoxidase. Both mutations introduced missense substitutions (Leu393Phe in one case and Phe397Leu in the other), resulting in a more than 100-fold higher MIC (9, 10). Antifungal resistance in many fungi is also mediated by overexpression of genes encoding multidrug transporters (1113). However, no resistance mediated by efflux pumps of the ATP-binding cassette (ABC) transporter family or by efflux pumps of the major facilitator family has yet been documented in dermatophyte clinical isolates.

Because of the incidence of patients with tinea pedis and tinea unguium insensitive to terbinafine treatment, the aims of this work are (i) to determine the frequency of terbinafine-resistant Trichophyton clinical isolates in a large screening of isolates from patients for whom a mycological analysis was performed at the Centre Hospitalier Universitaire Vaudois (CHUV) and (ii) to identify the mechanisms of resistance of dermatophytes insensitive to terbinafine.

RESULTS

Isolation of dermatophyte strains showing reduced susceptibility to terbinafine.

A total of 1,644 T. rubrum and 412 T. interdigitale clinical isolates, which were mainly collected from patients with tinea pedis or tinea unguium, were tested for growth ability on Sabouraud dextrose agar (SDA) containing 0.2 μg/ml terbinafine. Only 16 T. rubrum and one T. interdigitale isolate grew on the medium (Table 1). To investigate further the reduced terbinafine susceptibility of such strains, their squalene epoxidase (SQLE) genes were amplified by PCR and sequenced. As shown in Table 1, the SQLE genes of all the strains were revealed to contain point mutations leading to amino acid substitutions at one of four amino acid positions (Leu393, Phe397, Phe415, and His440) within the SQLE protein, strongly suggesting that a structural change in the SQLE protein might be involved in the reduced susceptibility of these strains to terbinafine.

TABLE 1.

Phenotypic and genotypic characteristics of the clinical isolates obtained from patients with dermatophyte infections

Species and isolate no.a Infection type Growth with terbinafineb Nucleotide substitution within the SQLE gene Amino acid substitution Terbinafine MIC (μg/ml) Fold expression of SQLE (mean ± SD)d
T. interdigitale
    ATCC MYA-4439 None None 0.00625 ND
T. rubrum
    CBS118892 None None NDc 1.08 ± 0.47
    TIMM20083 Tinea pedis +++ 1177TTA → TTT Leu393Phe 6.4 1.26 ± 0.48
    TIMM20084 Tinea pedis +++ 1177TTA → TTT Leu393Phe 3.2 0.67 ± 0.25
    TIMM20093 Tinea pedis +++ 1177TTA → TTT Leu393Phe 6.4 ND
    TIMM20094 Tinea unguium +++ 1177TTA → TTT Leu393Phe 6.4 ND
    TIMM20088 Tinea unguium +++ 1177TTA → TCA Leu393Ser 1.6 ND
    TIMM20095 Tinea unguium +++ 1177TTA → TCA Leu393Ser ND ND
    TIMM20085 Tinea unguium +++ 1189TTC → TTA Phe397Leu 3.2 ND
    TIMM20086 Tinea unguium +++ 1189TTC → CTC Phe397Leu 6.4 0.72 ± 0.29
    TIMM20087 Tinea unguium +++ 1189TTC → TTA Phe397Leu ND 0.64 ± 0.27
    TIMM20092 Tinea pedis +++ 1189TTC → CTC Phe397Leu >12.8 ND
    TIMM20091 Tinea pedis +++ 1189TTC → ATC Phe397Ile 0.8 ND
    TIMM20097 Tinea unguium + 1189TTC → GTC Phe397Val ND ND
    TIMM20090 Tinea unguium +++ 1305TTC → ATC Phe415Ile 0.1 ND
    TIMM20098 Tinea pedis + 1305TTC → TCC Phe415Ser ND ND
    TIMM20082 Tinea unguium +++ 1305TTC → GTC Phe415Val 0.4 ND
    TIMM20089 Tinea unguium + 1380CAT → TAT His440Tyr 0.1 ND
T. interdigitale
    TIMM20096 Tinea unguium +++ 1189TTC → CTC Phe397Leu 3.2 ND
a

All the clinical isolates were obtained in Switzerland and deposited in the culture collection of Teikyo University Institute of Medical Mycology (TIMM).

b

The growth ability of the clinical isolates on SDA containing 0.2 μg/ml terbinafine is indicated as weak (+) to vigorous (+++).

c

ND, not determined.

d

Results represent expression levels from three independent real-time PCR experiments. Expression levels of SQLE genes were indicated as relative fold changes compared to the CT mean of the wild-type strain CBS118892 data.

We used the length polymorphism of the tandem repetitive subelement 1 (TRS-1) and TRS-2 amplicons tentatively to differentiate T. rubrum resistant isolates carrying identical point mutations. The length polymorphism of TRS-1 allowed the differentiation of TIMM20083 and TIMM20093 from TIMM20084 and TIMM20094 (Fig. 1A). These four strains carried identical A-to-T substitutions at position 1179 of the open reading frame (ORF) of the SQLE gene, leading to the replacement of Leu393 by Phe in the SQLE protein. The length polymorphism of TRS-2 allowed the differentiation of TIMM20086 from TIMM20092 (Fig. 1B). These two strains carried identical T-to-C substitutions in position 1189 of the open reading frame of the SQLE gene, leading to the replacement of Phe397 by Leu in the SQLE protein. TIMM20085 and TIMM20087, which carried identical C-to-A substitutions at position 1191 of the open reading frame of the SQLE gene, could not be differentiated. Similar to TIMM20086 and TIMM20092, Phe397 was replaced by Leu in the SQLE protein.

FIG 1.

FIG 1

Agarose gel electrophoresis of the TRS-1 (lanes 1 to 4) and TRS-2 (lanes 5 to 8) regions from terbinafine-resistant T. rubrum clinical isolates with the same point mutation in the SQLE gene. (A) Strains with the replacement of Leu393 with Phe in SQLE. Lanes 1 and 5, TIMM20083; lanes 2 and 6, TIMM20084; lanes 3 and 7, TIMM20093; lanes 4 and 8, TIMM20094. (B) Strains with the replacement of Phe397 with Leu in the SQLE. Lanes 1 and 5, TIMM20085; lanes 2 and 6, TIMM20086; lanes 3 and 7, TIMM20087; lanes 4 and 8, TIMM20092. Leu397 is encoded by TTA in TIMM20085 and TIMM20087 and by CTC in TIMM20086 and TIMM20092.

The MIC values, measured by the broth microdilution method, varied from one isolate to another and appeared to depend on the detected mutation (Table 1). While the MIC values were almost the same for all Leu393Phe mutants, substantial differences were observed between Phe397Leu mutants. In particular, TIMM20092 showed a higher terbinafine tolerance than the other two Phe397Leu mutants (TIMM20085 and TIMM20086). The MIC values of TIMM20095 (Leu393Ser), TIMM20087 (Phe397Leu), TIMM20097 (Phe397Val), and TIMM20098 (Phe415Ser) were not estimated because these isolates dramatically decreased their conidial productivity.

Point mutations detected in the SQLE gene of resistant strains confer resistance to terbinafine.

We examined whether the single amino acid substitutions in the SQLE protein of the 17 Trichophyton isolates were involved in the terbinafine resistance phenotypes. Point mutations corresponding to the amino acid substitutions in these isolates were introduced into the endogenous SQLE gene of a terbinafine-sensitive dermatophyte strain by genetic manipulations. To enhance the generation of such mutations, Arthroderma vanbreuseghemii was used as a recipient organism, for which a variety of more efficient genetic manipulation tools have been developed than for T. rubrum and T. interdigitale (14). A. vanbreuseghemii, T. rubrum, and T. interdigitale SQLE genes each comprise a 1,532-bp ORF encoding 489 amino acids. The amino acid sequence of A. vanbreuseghemii SQLE (AvSQLE) is completely identical to that of T. interdigitale (GenBank accession number EZF33561). However, it differs in six amino acids at distinct positions (Val24, Thr52, Glu174, Asp352, Ala392, and Ile483) from that of T. rubrum SQLE (TrSQLE) (GenBank accession number EGD89476), with some potential impacts on the structure of mutated AvSQLE proteins expressed in A. vanbreuseghemii. Based on this possibility, expression of wild-type and mutated TrSQLE proteins in A. vanbreuseghemii was also investigated. The synthetic SQLE gene (designated sSQLE), which encodes the wild-type TrSQLE protein, and the SQLE gene alleles harboring point mutations leading to single amino acid substitutions in SQLE proteins were generated from the wild-type AvSQLE gene by overlap extension PCR. Four types of AvSQLE-targeting vectors harboring those alleles (Table 2) were constructed and introduced into the terbinafine-sensitive A. vanbreuseghemii strain 1062Av1401, according to the gene replacement strategy shown in Fig. 2A and B. Our initial attempt at transformation was unsuccessful, except for the production of transformants (named Av-FRT-1-3 and Tr-FRT-52-9, where FRT is FLP recombinase target) harboring the AvSQLE or sSQLE gene without any point mutation. However, subsequent attempts at transformation using these two clones as the recipient strains led to the successful production of clones harboring the mutated SQLE gene alleles, leading to the Leu393Phe, Leu393Ser, Phe397Ile, Phe397Leu, Phe397Val, Phe415Val, or His440Tyr substitution in AvSQLE and TrSQLE proteins (Fig. 2C). However, mutant strains harboring a Phe415Ser substitution could not be generated.

TABLE 2.

Plasmids used in this study

Plasmid Descriptiona Source or reference
pAg1 Streamlined version of the binary vector pBIN19 containing sequences necessary for replication in E. coli and A. tumefaciens (oriV and trfA), E. coli neomycin phosphotransferase (nptII), and the transferable DNA (T-DNA) region, with a multiple cloning site within the T-DNA region 37
pAg1-AbKu70/T2 AbKu70a fragment (the 5′ UTR of AbKu70 gene; 2.49 kb), 5′ FRT sequence, PtrpC (GenBank accession no. X02390), nptII, TcgrA (AFUA_8G02750), Pctr4 (TERG_01401), Pcflp, Ttrp1 (M74901), AbKu70b fragment (the 3′ UTR of AbKu70 gene; 2.19 kb) This study
pAg1-AvSQLE/T SQLEa fragment (5′-UTR and ORF of the AvSQLE gene; about 3.88 kb), 5′ FRT sequence, PtrpC, nptII, TcgrA, Pctr4, Pcflp, Ttrp1, 3′ FRT sequence, SQLEb fragment (the 3′-UTR of the AvSQLE gene; about 2.31 kb) This study
pAg1-mAvSQLE/T series SQLEa fragment (the 5′-UTR of AvSQLE gene and each mutated AvSQLE ORF leading to the Leu393Phe, Leu393Ser, Phe397Leu, Phe397Ile, Phe397Val, Phe415Ser, Phe415Val or His440Tyr substitution in AvSQLE) (3.88kb), 5′-FRT sequence, PtrpC, nptII, TcgrA, Pctr4, Pcflp, Ttrp1, 3′-FRT sequence, SQLEb fragment (the 3′-UTR of AvSQLE gene) (about 2.31kb) This study
pAg1-sSQLE/T SQLEa fragment (5′ UTR of the AvSQLE gene and the sSQLE ORF encoding wild-type TrSQLE; 3.88kb), 5′ FRT sequence, PtrpC, nptII, TcgrA, Pctr4, Pcflp, Ttrp1, 3′ FRT sequence, SQLEb fragment (the 3′ UTR of the AvSQLE gene; 2.31 kb) This study
pAg1-msSQLE/T series SQLEa fragment (5′ UTR of AvSQLE gene and each mutated sSQLE ORF leading to the Leu393Phe, Leu393Ser, Phe397Leu, Phe397Ile, Phe397Val, Phe415Ser, Phe415Val, or His440Tyr substitution in TrSQLE; 3.88kb), 5′ FRT sequence, PtrpC, nptII, TcgrA, Pctr4, Pcflp, Ttrp1, 3′ FRT sequence, SQLEb fragment (the 3′ UTR of the AvSQLE gene; about 2.31 kb) This study
a

ORF, open reading frame; sSQLE, synthetic SQLE.

FIG 2.

FIG 2

Introduction of point mutations into the endogenous SQLE gene of A. vanbreuseghemii by gene replacement strategy. (A) Schematic representation of a series of binary AvSQLE-targeting vectors. DNA fragments (SQLEa and SQLEb) containing the 5′ UTR of the AvSQLE gene and the open reading frames encoding wild-type and mutated A. vanbreuseghemii or T. rubrum SQLE proteins (ORF*) as well as the 3′ UTR of the AvSQLE gene were subcloned into the pAg1-AbKu70/T2 upstream (SpeI/ApaI) and downstream (BamHI/KpnI) of the PcFLP/FRT module, respectively (Table 2 and Fig. S1). The nptII cassette is composed of Aspergillus nidulans trpC promoter (PtrpC), E. coli neomycin phosphotransferase gene (nptII), and the A. fumigatus cgrA terminator (TcgrA). Pctr4, T. rubrum ctr4 promoter (34); Pcflp, the synthetic flp gene with Penicillium chrysogenum-optimized codon usage (35); Ttrp1, Cryptococcus neoformans trp1 terminator (36); FRT, FLP recombinase target sequence; LB and RB, left and right borders, respectively; A, ApaI; B, BamHI; C, ClaI; K, KpnI; Sc, SacI; Sh, SphI; Sp, SpeI. (B) Schematic representation of the AvSQLE locus before and after homologous recombination and excision of the PcFLP/FRT module. Site-specific recombination between the flanking FRT sequences was induced by conditional expression of Pcflp after transformation. All the internal BamHI sites contained in the amplified fragments were inactivated by overlap extension PCR. (C) Southern blotting. Aliquots of approximately 10 μg of total DNA from each mutant strain were digested with BamHI and separated by electrophoresis on 0.8% (wt/vol) agarose gels. 1062Av1401 indicates the parent strain. Lane 1, Av-FRT-1-3 (AvSQLE's control); lane 2, Av-S38A (Leu393Phe); lane 3, Av-1-3 (Leu393Ser); lane 4, Av-S714J6 (Phe397Leu); lane 5, Av-7-5 (Phe397Ile); lane 6, Av-4-1 (Phe397Val); lane 7, Av-S28M (Phe415Val); lane 8, Av-2-4 (His440Tyr); lane 9, Tr-FRT-52-9 (TrSQLE's control); lane 10, Tr-T31C (Leu393Phe); lane 11, Tr-2-3 (Leu393Ser); lane 12, Tr-T719J (Phe397Leu); lane 13, Tr-4-1 (Phe397Ile); lane 14, Tr-75-6 (Phe397Val); lane 15, Tr-T4B (Phe415Val); lane 16, Tr-2-1 (His440Tyr). A 566-bp fragment of the AvSQLE gene was amplified by PCR with the primer pair AvSQLE-F23 and AvSQLE-R21 (Table 4) and used as a hybridization probe. DNA standard fragment sizes are shown on the left.

The growth properties of the obtained A. vanbreuseghemii transformants harboring the mutated AvSQLE or sSQLE gene on solid medium containing terbinafine were compared with growth of the parent strain 1062Av1401. The two clones, i.e., Av-FRT-1-3 and Tr-FRT-52-9, which harbor the wild-type AvSQLE or sSQLE gene, were used as the control strains. As shown in Fig. 3, 1062Av1401, Av-FRT-1-3, and Tr-FRT-52-9 were unable to grow on SDA containing 0.005 μg/ml terbinafine, while all the clones harboring the mutated SQLE genes maintained growth activity. The MICs of terbinafine and itraconazole against these resistant clones were measured using the CLSI broth microdilution method (15). As shown in Table 3, clones that harbor the mutated AvSQLE and sSQLE genes were 8- to 512-fold less susceptible to terbinafine, respectively, than their respective control strains, demonstrating that the terbinafine tolerance of the clinical Trichophyton strains was conferred by single amino acid substitutions in the SQLE protein. Noteworthy clones with the Phe397Val substitution showed reduced growth rates (Fig. 4A). This finding has correlates with the observation that the clinical isolate TIMM20097 harboring the Phe397Val substitution grew slowly compared to growth of the wild-type T. rubrum and the isolate TIMM20085 harboring the Phe397Leu substitution (Fig. 4B). Similarly, the isolate TIMM20098 harboring the Phe415Ser substitution showed much more retarded growth than the wild-type T. rubrum and the isolate TIMM20082 harboring the Phe415Val substitution.

FIG 3.

FIG 3

The growth properties of A. vanbreuseghemii transformants expressing mutated AvSQLE and TrSQLE proteins on solid terbinafine-containing medium. Aliquots of 10 μl of conidial suspensions containing 1 × 105 cells were spotted onto SDA with (+) or without (−) 0.005 μg/ml terbinafine and incubated at 28°C for 3 days. Bar, 1.0 cm.

TABLE 3.

Susceptibilities to terbinafine and itraconazole of A. vanbreuseghemii transformants expressing mutated forms of the SQLE gene and corresponding expression levels

Species and strain Amino acid substitution MIC (μg/ml)
Fold expression of SQLE (mean ± SD)a
Terbinafine Itraconazole
T. interdigitale
    ATCC MYA-4439 None 0.00625 0.12 ND
A. vanbreuseghemii
    1062Av1401 None 0.0125 0.06 1.02 ± 0.24
    Av-FRT-1-3 None 0.00625 0.12 1.28 ± 0.06
    Av-S38A Leu393Phe 1.6 0.12 1.08 ± 0.11
    Av-1-3 Leu393Ser 0.4 0.12 ND
    Av-S714J6 Phe397Leu 3.2 0.12 1.37 ± 0.11
    Av-7-5 Phe397Ile 1.6 0.06 ND
    Av-S28 M Phe415Val 0.4 0.12 ND
    Av-2-4 His440Tyr 0.2 0.12 ND
T. rubrum
    Tr-FRT-52-9 None 0.00625 0.06 1.27 ± 0.14
    Tr-T31C Leu393Phe 3.2 0.12 1.63 ± 0.18
    Tr-2-3 Leu393Ser 0.4 0.06 ND
    Tr-T719J Phe397Leu 3.2 0.06 1.35 ± 0.16
    Tr-4-1 Phe397Ile 1.6 0.06 ND
    Tr-T4B Phe415Val 0.4 0.12 ND
    Tr-2-1 His440Tyr 0.05 0.25 ND
a

Results are from three independent real-time PCR experiments. ND, not determined. Expression levels of SQLE genes are indicated as relative fold changes compared to the CT mean of the parent strain 1062Av1401 data.

FIG 4.

FIG 4

The growth properties of A. vanbreuseghemii transformants with the substitution Phe397Val in the SQLE protein (A) and T. rubrum clinical isolates harboring the Phe397Val or Phe415Ser substitution in the SQLE protein (TIMM20097 or TIMM20098, respectively) in comparison to a Leu or Val residue, respectively (TIMM20085 and TIMM20082, respectively) (B) on solid medium. Aliquots of 10 μl of conidial suspensions containing 1 × 105 cells were spotted onto SDA and incubated at 28°C for 4 days (A) or 5 days (B). The wild-type T. rubrum CBS118892 was used as control. Bar, 1.0 cm.

No apparent difference was observed in the susceptibilities to itraconazole between transformants harboring the mutated SQLE genes and control strains (Table 3).

Comparative analysis of the SQLE gene expression levels among terbinafine-resistant dermatophyte strains.

To examine whether the resistance shown by A. vanbreuseghemii transformants was due to a point mutation in their SQLE genes or to different expression levels of polymorphic alleles in the heterologous host, quantitative real-time reverse transcription-PCR (qRT-PCR) was conducted. The SQLE gene expression levels in four T. rubrum clinical isolates and six A. vanbreuseghemii transformants, harboring the corresponding mutated SQLE genes or the wild-type alleles, were evaluated. Relative SQLE gene expression levels in the two control strains (Av-FRT-1-3 and Tr-FRT-52-9) did not show a significant difference from the level of their parent strain 1062Av1401 (Table 3). Likewise, no statistically significant differences in the SQLE gene expression levels were found between four A. vanbreuseghemii transformants and their respective parent strains, Av-FRT-1-3 and Tr-FRT-52-9 (Table 3). These results clearly indicate that resistance to terbinafine in A. vanbreuseghemii transformants was due to the respective point mutations. In addition, no statistically significant differences in SQLE gene expression levels were found between the four T. rubrum clinical isolates and the wild-type T. rubrum strain CBS118892 (Table 1).

DISCUSSION

Specific point mutations in squalene epoxidase genes causing terbinafine resistance.

Drug resistance of fungi has been increasing at an alarming rate over the past few decades. An understanding of the underlying molecular mechanisms is indispensable for successful therapies. In the current study, all 17 terbinafine-resistant Trichophyton clinical isolates were revealed to harbor squalene epoxidase (SQLE) gene alleles with point mutations, leading to amino acid substitutions at one of four amino acid positions (Leu393, Phe397, Phe415, and His440) within the SQLE protein. The single amino acid substitutions Leu393Phe and Phe397Leu in the SQLE protein have been previously reported, marking the first two cases of terbinafine-resistant T. rubrum strains isolated from patients (6, 9).

In a previous study, mutants of Saccharomyces cerevisiae resistant to terbinafine were generated by chemical, UV, and PCR-based mutagenesis, and molecular analysis revealed point mutations in the SQLE gene, leading to amino acid substitutions at one of five amino acid positions, Leu231, Phe402, Phe420, Pro430, and Phe433, in the SQLE protein (16). The residues Phe402 and Phe420 in S. cerevisiae SQLE correspond to Phe397 and Phe415 in T. rubrum SQLE, respectively. No amino acid substitutions equivalent to Leu231, Pro430, and Phe433 in S. cerevisiae SQLE were identified in the 17 terbinafine-resistant Trichophyton clinical isolates of the present study. Amino acid substitutions corresponding to Phe397Leu in the Trichophyton SQLE protein were also found in equivalent positions in the SQLE protein of Aspergillus fumigatus and Aspergillus nidulans terbinafine-resistant strains (17). Accordingly, point mutations at one of a few sites in the SQLE gene confer resistance to terbinafine in different fungi.

Identification of precise amino acid substitutions responsible for resistance to drugs is helpful in the determination of the interaction between the drugs and their targets. The atomic three-dimensional (3D) modeling of the S. cerevisiae SQLE protein was built based on previously available experimental findings, and, furthermore, it would screen the detailed amino acids critical for binding terbinafine to the enzyme (18). Among the 50 amino acids screened in that study, Phe402, Cys416, Phe417, Phe420, Tyr90, and Val92 seem to interact especially strongly with this agent. Similar to the S. cerevisiae SQLE protein, all of the amino acid substitutions found in the SQLE protein of the terbinafine-resistant Trichophyton clinical isolates reported in the present study and previously (6, 9) were also localized in the C-terminal region of SQLE. However, the A. vanbreuseghemii transformants carrying amino acid substitutions at Phe415, equivalent to Phe420 in the S. cerevisiae SQLE, were 4- to 8-fold more susceptible to terbinafine than those carrying amino acid substitutions at Leu393 and Phe397, equivalent to Leu398 and Phe402 in the S. cerevisiae SQLE protein (Table 3). Hence, there is a possibility that together with Phe397, Leu393 rather than Phe415 would make greater contributions to the SQLE-terbinafine firm contacts in Trichophyton species. In addition, His440 in the Trichophyton SQLE protein was shown to confer resistance to terbinafine for the first time in the present study. However, there is a valine (Val447) in the equivalent position of the S. cerevisiae SQLE protein, which was not screened by the 3D modeling study as an amino acid critical for binding terbinafine to the enzyme. These results suggest a subtle conformational difference of the terbinafine binding pocket within the enzyme between S. cerevisiae and Trichophyton SQLE proteins, possibly leading to the difference in their susceptibilities to this agent. Alternatively, an amino acid substitution may cause conformational changes in the enzyme that result in reduced drug affinity.

Transfer of terbinafine resistance from one isolate to another.

To investigate the relationship between these amino acid substitutions and terbinafine tolerance, point mutations leading to several amino acid substitutions found in the SQLE protein of the Trichophyton clinical isolates were introduced into the endogenous SQLE gene of the dermatophyte Arthroderma vanbreuseghemii using genetic manipulation tools. As shown in Table 3, all of the A. vanbreuseghemii transformants expressing mutated SQLE proteins showed significant reductions in susceptibilities to terbinafine, demonstrating that the amino acid substitutions in the SQLE protein are a major cause of the terbinafine resistance in Trichophyton clinical isolates. Interestingly, transformants with the Phe397Val substitution displayed retarded growth (Fig. 4A). The clinical isolates TIMM20097 and TIMM20098 harboring the Phe397Val and Phe415Ser substitutions, respectively, also grew slowly compared to growth of the wild-type T. rubrum and the isolates TIMM20085 and TIMM20082 harboring the Phe397Leu and Phe415Val substitutions, respectively (Fig. 4B). These results suggest the possibility that the Phe397Val and Phe415Ser substitutions in the SQLE protein affect both the susceptibility to terbinafine and the squalene epoxidase activity. The report of fluconazole resistance in Candida albicans associated with reduced affinity of sterol 14-α-demethylase (target of fluconazole) supports this hypothesis (19). Similarly, the growth of TIMM20098 was more retarded than that of TIMM20097 (Fig. 4B). This may explain why A. vanbreuseghemii transformants harboring the Phe415Ser substitution could not be successfully generated.

The discrepancy in terbinafine tolerance of our clinical isolates with the same Phe397Leu mutation, particularly TIMM20092 displaying higher tolerance, could be explained by additional mechanisms of resistance (Table 1). This hypothesis is supported by the abundant work on resistance to azole antifungal agents in Candida albicans. The fungal target of these agents is a cytochrome P450 encoded by the gene ERG11. Azole resistance of clinical isolates of C. albicans was mediated by various mechanisms, including missense mutations in ERG11 and overexpression of genes encoding multidrug transporters, and combined effects of such mechanisms were observed in the same azole-resistant clinical isolate (20). It is possible that overexpression of genes coding for efflux pumps are also involved in terbinafine tolerance in some of our clinical isolates. Moreover, disruption of a multidrug transporter in T. rubrum resulted in an increased sensitivity to terbinafine among various tested antifungal compounds, which was 2-fold higher than that of the nonmutated strains cloned (21).

Selectable markers used in site-directed mutagenesis may also have effects on the susceptibility of generated mutants. A recent study on succinate dehydrogenase (Sdh), the primary molecular target of the novel antifungal agent ME1111, showed that the selectable marker cassette harboring the E. coli hygromycin B phosphotransferase gene could increase the susceptibility to the drug (22). The finding was evidenced by the fact that the generated control strains harboring the wild-type gene and the selectable marker cassette were more susceptible to ME1111 than the recipient host strain or reference strain. Hence, there is a possibility that the selectable marker, which was retained in the downstream region of the ORFs of each subunit gene, could confer reduced expression of such genes. To obviate the possibility, the point mutations in the present study were introduced into the endogenous SQLE gene of A. vanbreuseghemii using an FLP recombinase-mediated site-specific recombination system derived from S. cerevisiae (Fig. 2A and B). Following transformation of a recipient strain using each SQLE-targeting vector, the selectable marker (E. coli neomycin phosphotransferase gene) cassette was excised from the SQLE locus in the transformants by FLP recombinase-mediated site-specific recombination between the flanking FRT sequences. Nevertheless, an FRT site remained between the coding sequence of the gene and its downstream region. The FRT sequence is an inverted repeat and thus may affect transcription, mRNA secondary structure, and transcript stability. However, differences in transcription levels of the target gene with and without the added FRT sequence were found to be not statistically significant (Table 3). Moreover, as shown in Table 3, the generated marker-free control strains (Av-FRT-1-3 and Tr-FRT-52-9) showed susceptibilities to terbinafine and itraconazole that are nearly identical to those in the parent strain (1062Av1401) and the reference strain (T. interdigitale ATCC MYA-4439). The inserted wild-type gene could serve as a proper control for comparison with the mutated alleles.

High frequency of terbinafine-resistant isolates.

The frequency of our terbinafine-resistant clinical isolates of about 1% is strikingly high, considering that the average size of genomes of dermatophytes is about 22 Mb (23). The various sizes of the amplicons obtained by specifically amplifying subrepeat elements in the ribosomal DNA nontranscribed spacer attested that different isolates with identical mutations did not belong to the same strain. Therefore, we could exclude the possibility of the propagation of a particular resistant strain in several patients. We also excluded the possibility that resistance was developed during our screening on SDA containing terbinafine for two reasons. (i) Trichophyton isolates were from patients with tinea pedis and/or onychomycosis who did not respond to terbinafine treatment. In three cases where a remaining portion of the sample was stored, the SQLE gene could be amplified by targeting total DNA extracted from nails, which was found to harbor a mutation identical to that identified in cultured Trichophyton (data not shown). (ii) The development of resistance to terbinafine in T. rubrum was found to occur at a rare frequency in vitro (10). Moreover, no resistant T. rubrum strain was generated from a terbinafine-sensitive strain used as a negative control, which was always added with a terbinafine-resistant strain as a positive control in each test plate during the screening procedure.

To explain this high frequency of terbinafine-resistant strains, it should be considered that treatments with terbinafine involve a prolonged exposure to the antifungal drug, which could favor the selection of resistant strains. This hypothesis is supported by the finding that fluconazole resistance in C. albicans is correlated with the total dose of fluconazole administered to patients (24). The emergence of C. albicans strains that are less susceptible to this antifungal agent is favored by the uptake of a total dose of fluconazole of more than 5 g (24). Retrospective analysis of the follow-up of patients revealed that 8 of the 17 patients harboring a terbinafine-resistant Trichophyton isolate had already been treated with terbinafine when the skin and/or nail sample was sent to the laboratory for mycological analysis. One patient was apparently not pretreated. Complete data were not available for eight patients. Prospective studies would be of interest to confirm the possible emergence of resistant strains during long-term treatment.

MATERIALS AND METHODS

Strains and medium.

Trichophyton interdigitale ATCC MYA-4439 and T. rubrum CBS118892 were obtained from the American Type Culture Collection (Manassas, VA) or CBS-KNAW Culture Collections (Utrecht, Netherlands). Arthroderma vanbreuseghemii (formerly T. mentagrophytes) 1062Av1401 (25), which lacks a homolog of the human Ku80 (26), was used as a recipient strain for genetic manipulation. Microconidium formation was induced at 28°C using modified 1/10 Sabouraud dextrose agar (SDA) (27) supplemented with 500 μg/ml cycloheximide (Wako Chemical) and 50 μg/ml chloramphenicol (Sigma-Aldrich). Agrobacterium tumefaciens EHA105 (28) was maintained as previously described (29). Escherichia coli DH5α (Nippon Gene) was used for molecular cloning.

Screening of Trichophyton isolates resistant to terbinafine.

Over a 3-year period (2013 to 2016), 1,644 T. rubrum and 412 T. interdigitale isolates were obtained from clinical samples sent to the CHUV for mycological analysis. The samples were mainly collected from patients with tinea pedis or tinea unguium. All clinical isolates were tested for fungal growth on SDA containing 0.2 μg/ml terbinafine, a quantity equivalent to twice that of the MIC for T. rubrum and T. interdigitale under these conditions (30). Examination of fungal growth was performed after 7, 10, and 14 days. Growing strains were kept and stored in Lausanne and Tokyo in SD broth supplemented with glycerol and dimethyl sulfoxide (DMSO) at −80°C pending further analysis. Isolated terbinafine-resistant strains were deposited in the culture collection of the Teikyo University Institute of Medical Mycology (TIMM) under the identification numbers given in Table 1.

Trichophyton total DNA extraction and SQLE gene analysis.

Trichophyton total DNA was extracted from fresh fungal cultures on SD agar medium and nail samples as previously described using a DNeasy Plant minikit (Qiagen) (31). A diameter of approximately 0.5 cm of growing mycelium was used. Before DNA extraction, nail fragments (20 to 100 mg) were incubated overnight in 500 μl of sodium sulfide dissolving solution (10% [wt/vol] Na2S, 25% [vol/vol] ethanol). After centrifugation at 8,000 × g for 2 min, the sample precipitate containing fungal elements was washed twice with distilled water. The SQLE gene of the terbinafine-resistant clinical isolates was amplified by PCR with High Fidelity DNA Polymerase (Roche Diagnostics), the primer pair TrSQLE-F1 and TrSQLE-R1, and chromosomal DNA as the template. Nucleotide sequences of these primers are shown in Table 4.

TABLE 4.

PCR primers used in this study

Purpose Primer Sequence (5′–3′)b Note
Amplification of SQLE genes for qRT-PCR qRT_erg1_2-F CCAGACTGATGGCAAGCAAGA
qRT_erg1_2-R ATAAGCTCCAGGCCCCAGAA
qRT_erg(Tr)1_2-F CCAGACTGATGGCAAACAAGA
Amplification of SQLE genes from clinical isolates TrSQLE-F1 ATGGTTGTAGAGGCTCCTCCC
TrSQLE-R1 CTAGCTTTGAAGTTCGGCAAA
Amplification of the DNA fragments containing the 5′ UTR of AvSQLE and the SQLE ORF AvSQLE-F15/SpeI TCACGAAGCTAACTAGTACCTGAAAGATGAC Inactivation of the KpnI site
AvSQLE-R23/ApaI AAAAAGGGCCCCTAGCTTTGAAGTTCGGCAAATA
Amplification of the 3′ UTR fragment of AvSQLE AvSQLE-F13/BamHI CAAGGATCCACAGATAGGCTTATCTCTAGCTCT
AvSQLE-R16/KpnI CAGGGTACCTCCGTTCATAGTCAACGAACGTCTCG
Generation of the sSQLE ORF encoding wild-type TrSQLEa AvSQLE-F21 TCCGCGAAGCCCAAGGTATACCGCGACGAA Ala24Val
AvSQLE-R18 TTCGTCGCGGTATACCTTGGGCTTCGCGGA
AvSQLE-F22 GGCATTGCTGGATGTACGCTGGCCGTTGCGTT Ala52Thr
AvSQLE-R19 AACGCAACGGCCAGCGTACATCCAGCAATGCC
AvSQLE-F23 TCCACGCACACAGGGGAGGTCCTTGGAGTTCAATG Asp174Glu
AvSQLE-R20 CATTGAACTCCAAGGACCTCCCCTGTGTGCGTGGA
AvSQLE-F24 ATGTCGTTCTCCTCCGGGATCTACTTAGTCCAGA Asn352Asp, hybridization probe
AvSQLE-R21 TCTGGACTAAGTAGATCCCGGAGGAGAACGACAT
AvSQLE-F25 TCAATATTCTTGCCCAGGCCTTATACTCTATATTC Ser392Ala
AvSQLE-R22 GAATATAGAGTATAAGGCCTGGGCAAGAATATTGA
AvSQLE-F26 GGTCATCCTTCCTTTCATATTTGCCGAACTT Val483Ile
AvSQLE-R24 AAGTTCGGCAAATATGAAAGGAAGGATGACC
Generation of point mutations in AvSQLE and TrSQLEa AvSQLE-F27 TTGCCCAGTCCTTCTACTCTATATT Leu393Phe (AvSQLE)
AvSQLE-R27 AATATAGAGTAGAAGGACTGGGCAA
AvSQLE-F29 TTCTTGCCCAGGCCTTCTACTCTATATT Leu393Phe (TrSQLE)
AvSQLE-R29 AATATAGAGTAGAAGGCCTGGGCAAGAA
AvSQLE-F35 TTGCCCAGTCCTCATACTCTATATT Leu393Ser (AvSQLE)
AvSQLE-R35 AATATAGAGTATGAGGACTGGGCAA
AvSQLE-F36 TTCTTGCCCAGGCCTCATACTCTATATT Leu393Ser (TrSQLE)
AvSQLE-R36 AATATAGAGTATGAGGCCTGGGCAAGAA
AvSQLE-F28 TACTCTATATTAGCCGCTGGTG Phe397Leu (both SQLE proteins)
AvSQLE-R28 CACCAGCGGCTAATATAGAGTA
AvSQLE-F31 TACTCTATAATCGCCGCTGGTG Phe397Ile (both SQLE proteins)
AvSQLE-R31 CACCAGCGGCGATTATAGAGTA
AvSQLE-F30 TACTCTATAGTCGCCGCTGGTG Phe397Val (both SQLE proteins)
AvSQLE-R30 CACCAGCGGCGACTATAGAGTA
AvSE-F37 GGCTGCTTCAGGTATTCCCAACTTGGACTTATA Phe415Ser (both SQLE proteins)
AvSE-R37 TATAAGTCCAAGTTGGGAATACCTGAAGCAGCC
AvSQLE-F14 GGCTGCTTCAGGTATGTCCAACTTGGACTTATA Phe415Val (both SQLE proteins)
AvSQLE-R8 TATAAGTCCAAGTTGGACATACCTGAAGCAGCC
AvSQLE-F29 CCTTGGTTCTATTACGATATTTTTACTCCGTAGCC His440Tyr (both SQLE proteins)
AvSQLE-R29 GGCTACGGAGTAAAAATATCGTAATAGAACCAAGG
a

Introduction of nucleotide substitutions into SQLE genes by overlap extension PCR.

b

Restriction sites are underlined, and substitutions are in boldface.

Trichophyton rubrum strain typing.

Strain typing based on the length of the parts containing the tandem repetitive subelements (TRSs), TRS-1 and TRS-2, in nontranscribed spacers of ribosomal DNA (ribosomal DNA intergenic spacer regions) was performed as described by Jackson et al. (32). The primer pair TrNTSF-2 and TrNTSR-4 and the pair TrNTSC-1 and TrNTSR-1 were used to amplify the TRS-1 and the TRS-2 regions, respectively (32). Strains were characterized by the size of both TRS-1 and TRS-2 amplicons, which are polymorphic for length.

Construction of transformation vectors harboring wild-type and mutated SQLE.

Genomic data of the SQLE locus that shares homology with the T. rubrum SQLE gene (TrSQLE) (GenBank accession number TERG_05717) were identified in A. vanbreuseghemii based on GenBank accession number AB690298 and our private draft genome of the strain TIMM2789. A. vanbreuseghemii SQLE (designated AvSQLE) differs in six amino acids at distinct positions (Val24, Thr52, Glu174, Asp352, Ala392, and Ile483) from TrSQLE (GenBank accession number EGD89476). To generate the SQLE ORF fragment encoding the wild-type TrSQLE protein, six point mutations were introduced into the AvSQLE gene by overlap extension PCR with the corresponding six pairs of primers (listed in Table 4); the resultant fragment was designated sSQLE (where s indicates synthetic gene). The SQLE gene alleles harboring point mutations leading to Leu393Phe, Leu393Ser, Phe397Leu, Phe397Ile, Phe397Val, Phe415Ser, Phe415Val, or His440Tyr in AvSQLE and TrSQLE were also generated from the wild-type AvSQLE gene by overlap extension PCR with the corresponding pair of primers (listed in Table 4). All the amplified fragments were sequenced to verify the introduction of correct nucleotide substitutions at the targeted sites.

To construct a series of AvSQLE locus-targeting binary vectors, two types of DNA fragments were amplified by PCR; the SQLEa fragment contained the 5′ untranslated region (UTR) of the AvSQLE gene and each SQLE ORF, and the SQLEb fragment contained the 3′ UTR of the AvSQLE gene (Fig. 2A). Each fragment was doubly digested with the SpeI/ApaI or the BamHI/KpnI enzymes, respectively, and subsequently subcloned into the binary vector pAg1-AbKu70/T2 (Table 2; see Fig. S1 in the supplemental material), resulting in the replacement of the 5′ UTR and 3′ UTR fragments of the Arthroderma benhamiae Ku70 gene (ARB_06096) within the vector. Depending on the SQLE ORF contained in the SQLEa fragment, four types of vectors were generated: pAg1-AvSQLE/T and pAg1-sSQLE/T harboring the AvSQLE ORF and the sSQLE ORF encoding the wild-type TrSQLE protein, respectively, and the pAg1-mAvSQLE/T and pAg1-msSQLE/T (where m indicates mutated gene constructs) series harboring the ORF of each mutated SQLE allele, which contained a point mutation leading to the Leu393Phe, Leu393Ser, Phe397Leu, Phe397Ile, Phe397Val, Phe415Ser, Phe415Val, or His440Tyr substitution in AvSQLE and TrSQLE proteins, respectively (Table 2).

The PCRs were performed using PrimeSTAR HS DNA polymerase or Extaq DNA polymerase (TaKaRa Bio). If necessary, the amplified fragments were gel purified with a QIAEX II gel extraction kit (Qiagen). All the internal ApaI, BamHI, KpnI, and SpeI sites contained in the amplified fragments were inactivated by overlap extension PCR with a corresponding pair of primers (Table S1).

Fungal genetic transformation.

A. vanbreuseghemii 1062Av1401 was transformed by the A. tumefaciens-mediated transformation (ATMT) method as described previously (29). After cocultivation, nylon membranes were transferred onto SDA containing 250 μg/ml G418 (Sigma-Aldrich) and 10 μM CuSO4·7H2O, and overlaid with 10 ml of SDA supplemented with the same concentration of G418 and CuSO4·7H2O. The plates were further overlaid after 48 h with 10 ml of SDA containing 350 μg/ml G418 and 10 μM CuSO4·7H2O and then incubated for 4 to 5 days. The colonies regenerating on the selective medium were considered putative G418-resistant clones and transferred onto solid morpholinepropanesulfonic acid (MOPS)-buffered RPMI 1640 medium (RPMI 1640A) supplemented with 500 μg/ml cycloheximide, 50 μg/ml chloramphenicol, 200 μg/ml cefotaxime sodium (Sanofi-Aventis) (if necessary), and 20 μM bathocuproine disulfonate (BCS) (Dojindo Laboratories) and passaged several times. The T. rubrum ctr4 promoter (Pctr4) is a conditional promoter that is repressed in the presence of copper. Chelation of copper by bathocuproine sulfate activates the Pctr4, leading to the induction of Penicillium chrysogenum flp (Pcflp) gene expression. Expression of PcFLP recombinase leads to excision of the selectable marker via PcFLP-mediated site-specific recombination between the flanking FRT sequences.

Screening of the desired transformants.

The desired transformants were finally screened by PCR, Southern blotting analyses, and nucleotide sequencing. Total DNA was extracted according to a method described previously (29). Aliquots of 50 to 100 ng of the total DNA were used as templates in the PCRs. For Southern blotting, aliquots of approximately 10 μg of the total DNA were digested with an appropriate restriction enzyme, separated by electrophoresis on 0.8% (wt/vol) agarose gels, and transferred onto Hybond-N+ membranes (GE Healthcare Ltd.). Southern hybridization was performed using an ECL Direct Nucleic Acid Labeling and Detection System (GE Healthcare Ltd.) according to the manufacturer's instructions.

Drug susceptibility testing.

MICs were determined according to the broth microdilution method of the Clinical and Laboratory Standards Institute (15).

Total RNA extraction and qRT-PCR.

Plugs from fresh cultures of five T. rubrum strains (CBS118892, TIMM20083, TIMM20084, TIMM20086, and TIMM20087) and seven A. vanbreuseghemii strains (1062Av1401, Av-FRT-1-3, AvS38A, AvS714J6, Tr-FRT-52-9, Tr-T31C, and Tr-T719J) grown on SDA were inoculated in about 15 ml of RPMI 1640 broth and cultivated at 28°C on a rotary shaker at 200 rpm. After 3 days, the growing mycelia from each strain were collected, frozen, and ground under liquid nitrogen with a Multi-Beads shocker (Yasui Kikai) at 1,800 rpm for 10 s, which was repeated 3 times. Total RNA was extracted using an RNeasy Plant minikit (Qiagen) and was treated with DNase I (Invitrogen). First-strand cDNA was synthesized using a high-capacity RNA-to-cDNA kit (Applied Biosystems). The quantitative real-time reverse transcription-PCR (qRT-PCR) analysis was performed using Fast SYBR green PCR master mix on an ABI PRISM 7500 Fast real-time PCR system (Applied Biosystems) under standard conditions, according to the manufacturer's recommendations. Two sets of primers were used, one to amplify SQLE alleles derived from A. vanbreuseghemii (qRT_erg1_2-F and qRT_erg1_2-R) and the other to amplify SQLE alleles derived from T. rubrum [qRT_erg(Tr)1_2-F and qRT_erg1_2-R] (Table 4). Dissociation curves of the q PCR-amplified products were plotted to confirm the absence of nonspecific products or primer dimers. Normalization was done to the 18S rRNA gene using two primers, 18S-1-F and 18S-1-R (33), and relative quantification of gene expression was calculated according to the 2−ΔΔCT (where CT is threshold cycle) method. Expression levels of SQLE genes examined in six A. vanbreuseghemii transformants and four T. rubrum clinical isolates are indicated as relative fold changes compared to levels in the A. vanbreuseghemii parent strain 1062Av1401 or the wild-type T. rubrum strain CBS118892, respectively. Statistical significance of SQLE gene expression levels among strains was evaluated using Student's t test.

Nucleotide sequence accession number.

The nucleotide sequence of the A. vanbreuseghemii SQLE (AvSQLE) locus containing the ORF was deposited in the GenBank under accession number KU242352.

Supplementary Material

Supplemental material

ACKNOWLEDGMENTS

We thank Junko Ito (Chiba University Medical Mycology Research Center, Chiba, Japan) for technical support in the drug susceptibility tests of dermatophyte strains by the microdilution method of the Clinical and Laboratory Standards Institute (CLSI M38-A2).

This study was partly supported by the National BioResource Project—Pathogenic Microbes in Japan and the Joint Usage/Research Program of the Medical Mycology Research Center, Chiba University (grant number 16-26).

Footnotes

Supplemental material for this article may be found at https://doi.org/10.1128/AAC.00115-17.

REFERENCES

  • 1.Monod M, Jaccoud S, Zaugg C, Léchenne B, Baudraz F, Panizzon R. 2002. Survey of dermatophyte infections in the Lausanne area, Switzerland. Dermatology 205:201–203. doi: 10.1159/000063913. [DOI] [PubMed] [Google Scholar]
  • 2.Reiss E, Shadomy HJ, Lyon GM. 2011. Fundamental medical mycology, p 527–565. Wiley-Blackwell, Hoboken, NJ. [Google Scholar]
  • 3.Reiss E, Shadomy HJ, Lyon GM. 2011. Fundamental medical mycology, p 75–105. Wiley-Blackwell, Hoboken, NJ. [Google Scholar]
  • 4.Odds FC, Brown AJ, Gow NA. 2003. Antifungal agents: mechanisms of action. Trends Microbiol 11:272–279. doi: 10.1016/S0966-842X(03)00117-3. [DOI] [PubMed] [Google Scholar]
  • 5.Takami T, Fang Y, Zhou X, Jaiseng W, Ma Y, Kuno T. 2012. A genetic and pharmacological analysis of isoprenoid pathway by LC-MS/MS in fission yeast. PLoS One 7:e49004. doi: 10.1371/journal.pone.0049004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. 2003. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 47:82–86. doi: 10.1128/AAC.47.1.82-86.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Favre B, Ghannoum MA, Ryder NS. 2004. Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates. Med Mycol 42:525–529. doi: 10.1080/13693780410001661482. [DOI] [PubMed] [Google Scholar]
  • 8.Osborne CS, Leitner I, Favre B, Ryder NS. 2005. Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine. Antimicrob Agents Chemother 49:2840–2844. doi: 10.1128/AAC.49.7.2840-2844.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Osborne CS, Leitner I, Hofbauer B, Fielding CA, Favre B, Ryder NS. 2006. Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine. Antimicrob Agents Chemother 50:2234–2236. doi: 10.1128/AAC.01600-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Osborne CS, Hofbauer B, Favre B, Ryder NS. 2003. In vitro analysis of the ability of Trichophyton rubrum to become resistant to terbinafine. Antimicrob Agents Chemother 47:3634–3636. doi: 10.1128/AAC.47.11.3634-3636.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39:2378–2386. doi: 10.1128/AAC.39.11.2378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sanglard D, Ischer F, Koymans L, Bille J. 1998. Amino acid substitutions in the cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 42:241–253. doi: 10.1093/jac/42.2.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Morschhäuser J. 2010. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 47:94–106. doi: 10.1016/j.fgb.2009.08.002. [DOI] [PubMed] [Google Scholar]
  • 14.Alshahni MM, Yamada T. 2017. Genetic manipulations in dermatophytes. Mycopathologia 182:33–43. doi: 10.1007/s11046-016-0039-y. [DOI] [PubMed] [Google Scholar]
  • 15.Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd ed CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
  • 16.Leber R, Fuchsbichler S, Klobucníková V, Schweighofer N, Pitters E, Wohlfarter K, Lederer M, Landl K, Ruckenstuhl C, Hapala I, Turnowsky F. 2003. Molecular mechanism of terbinafine resistance in Saccharomyces cerevisiae. Antimicrob Agents Chemother 47:3890–3900. doi: 10.1128/AAC.47.12.3890-3900.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rocha EMF, Gardiner RE, Park S, Martinez-Rossi NM, Perlin DS. 2006. A Phe389Leu substitution in ErgA confers terbinafine resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 50:2533–2536. doi: 10.1128/AAC.00187-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nowosielski M, Hoffmann M, Wyrwicz LS, Stepniak P, Plewczynski DM, Lazniewski M, Ginalski K, Rychlewski L. 2011. Detailed mechanism of squalene epoxidase inhibition by terbinafine. J Chem Infect Model 51:455–462. doi: 10.1021/ci100403b. [DOI] [PubMed] [Google Scholar]
  • 19.Kelly SL, Lamb DC, Loeffler J, Einsele H, Kelly DE. 1999. The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity. Biochem Biophys Res Commun 262:174–179. doi: 10.1006/bbrc.1999.1136. [DOI] [PubMed] [Google Scholar]
  • 20.MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D. 2010. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection. Antimicrob Agents Chemother 54:1476–1483. doi: 10.1128/AAC.01645-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Fachin AL, Ferreira-Nozawa MS, Maccheroni W Jr, Martinez-Ros si NM. 2006. Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum. J Med Microbiol 55:1093–1099. doi: 10.1099/jmm.0.46522-0. [DOI] [PubMed] [Google Scholar]
  • 22.Takahata S, Kubota N, Takei-Masuda N, Yamada T, Maeda M, Alshahni MM, Abe S, Tabata Y, Maebashi K. 2016. Mechanism of action of ME1111, a novel antifungal agent for topical treatment of onychomycosis. Antimicrob Agents Chemother 60:873–880. doi: 10.1128/AAC.01790-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Martinez DA, Oliver BG, Gräser Y, Goldberg JM, Li W, Martinez-Rossi NM, Monod M, Shelest E, Barton RC, Birch E, Brakhage AA, Chen Z, Gurr SJ, Heiman D, Heitman J, Kosti I, Rossi A, Saif S, Samalova M, Saunders CW, Shea T, Summerbell RC, Xu J, Young S, Zeng Q, Birren BW, Cuomo CA, White TC. 2012. Comparative genome analysis of Trichophyton rubrum and related dermatophytes reveals candidate genes involved in infection. mBio 3:e00259-12. doi: 10.1128/mBio.00259-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, Michel-Briand Y. 1994. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 32:1115–1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yamada Y, Maeda M, Alshahni MM, Monod M, Staib P, Yamada T. 2014. Flippase (FLP) recombinase-mediated marker recycling in the dermatophyte Arthroderma vanbreuseghemii. Microbiology 160:2122–2135. doi: 10.1099/mic.0.076562-0. [DOI] [PubMed] [Google Scholar]
  • 26.Mimori T, Ohosone Y, Hama N, Suwa A, Akizuki M, Homma M, Griffith AJ, Hardin JA. 1990. Isolation and characterization of cDNA encoding the 80-kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome. Proc Natl Acad Sci U S A 87:1777–1781. doi: 10.1073/pnas.87.5.1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Uchida K, Tanaka T, Yamaguchi H. 2003. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis. Microbiol Immunol 47:143–146. doi: 10.1111/j.1348-0421.2003.tb02797.x. [DOI] [PubMed] [Google Scholar]
  • 28.Hood EE, Gelvin SB, Melchers LS, Hoekema A. 1993. New Agrobacterium helper plasmids for gene transfer to plants. Transgenic Res 2:208–218. doi: 10.1007/BF01977351. [DOI] [Google Scholar]
  • 29.Yamada T, Makimura K, Satoh K, Umeda Y, Ishihara Y, Abe S. 2009. Agrobacterium tumefaciens-mediated transformation of the dermatophyte, Trichophyton mentagrophytes: an efficient tool for gene transfer. Med Mycol 47:485–494. doi: 10.1080/13693780802322240. [DOI] [PubMed] [Google Scholar]
  • 30.Mock M, Monod M, Baudraz-Rosselet F, Panizzon RG. 1998. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo. Dermatology 197:361–367. doi: 10.1159/000018032. [DOI] [PubMed] [Google Scholar]
  • 31.Verrier J, Pronina M, Peter C, Bontems O, Fratti M, Salamin K, Schürch S, Gindro K, Wolfender JL, Harshman K, Monod M. 2012. Identification of infectious agents in onychomycoses by PCR-terminal restriction fragment length polymorphism. J Clin Microbiol 50:553–561. doi: 10.1128/JCM.05164-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jackson CJ, Barton RC, Kelly SL, Evans EGV. 2000. Strain identification of Trichophyton rubrum by specific amplification of subrepeat elements in the ribosomal DNA nontranscribed spacer. J Clin Microbiol 38:4527–4534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Diao Y, Zhao R, Deng X, Leng W, Peng J, Jin Q. 2009. Transcriptional profiles of Trichophyton rubrum in response to itraconazole. Med Mycol 47:237–247. doi: 10.1080/13693780802227308. [DOI] [PubMed] [Google Scholar]
  • 34.Iwata A, Alshahni MM, Nishiyama Y, Makimura K, Abe S, Yamada T. 2012. Development of a tightly regulatable copper-mediated gene switch system in dermatophytes. Appl Environ Microbiol 78:5204–5211. doi: 10.1128/AEM.00464-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kopke K, Hoff B, Kück U. 2010. Application of the Saccharomyces cerevisiae FLP/FRT recombination system in filamentous fungi for marker recycling and construction of knockout strains devoid of heterologous genes. Appl Environ Microbiol 76:4664–4674. doi: 10.1128/AEM.00670-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Alshahni MM, Yamada T, Makimura K, Takatori K, Sawada T. 2010. Nourseothricin acetyltransferase: a new dominant selectable marker for the dermatophyte Trichophyton mentagrophytes. Med Mycol 48:665–668. doi: 10.3109/13693780903330555. [DOI] [PubMed] [Google Scholar]
  • 37.Zhang A, Lu P, Dahl-Roshak AM, Paress PS, Kennedy S, Tkacz JS, An Z. 2003. Efficient disruption of a polyketide synthase gene (pks1) required for melanin synthesis through Agrobacterium-mediated transformation of Glarea lozoyensis. Mol Genet Genomics 268:645–655. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental material

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES